跳至主要内容
临床试验/NCT03775473
NCT03775473终止不适用

Dosage of Progastrin in Asymptomatic Person Participating in Colon Cancer Screening

ECS-Progastrin SA2 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2019年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
260
试验地点
2
主要终点
progastrin rate

研究概览

简要总结

Dosage of progastrin in asymptomatic person participating in colon cancer screening

详细描述

For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • participant in colon cancer screening
  • signing informed consent

排除标准

  • any major medical, psychiatric or addictive illness that would affect the informed consent process
  • The consent of a representative is not allowed in this study

结局指标

主要结局

progastrin rate

时间窗: from 15 days to 2 months (until results are obtained)

measuring the rate of progastrin in the blood

次要结局

未报告次要终点

研究者

发起方
ECS-Progastrin SA
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验